Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of SR-0379 Spray in Patients With Skin Ulcer Requiring Surgical Closure
jRCT2031210266Phase 3Completed
- Sponsor
- FunPep
- Start
- Aug 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Cutaneous ulcer comparing SR-0379 spray with Placebo spray (2 arms). Primary endpoint: Time to simple surgical intervention. Started Aug 2021; status: completed.
02
Drugs
SR-0379
03
Conditions
Cutaneous ulcer
Beyond the preview
Go deeper on jRCT2031210266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031210266.